ATE235487T1 - S-oxyde lipide senkende verbindungen - Google Patents

S-oxyde lipide senkende verbindungen

Info

Publication number
ATE235487T1
ATE235487T1 AT99964594T AT99964594T ATE235487T1 AT E235487 T1 ATE235487 T1 AT E235487T1 AT 99964594 T AT99964594 T AT 99964594T AT 99964594 T AT99964594 T AT 99964594T AT E235487 T1 ATE235487 T1 AT E235487T1
Authority
AT
Austria
Prior art keywords
lipide
oxyde
lowering compounds
lowering
compounds
Prior art date
Application number
AT99964594T
Other languages
English (en)
Inventor
Cornelus Gerardus Mari Janssen
Peter Walter Maria Roevens
Jozef Bertha August Thijssen
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE235487T1 publication Critical patent/ATE235487T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99964594T 1998-12-22 1999-12-14 S-oxyde lipide senkende verbindungen ATE235487T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204410 1998-12-22
PCT/EP1999/010065 WO2000037463A1 (en) 1998-12-22 1999-12-14 S-oxide lipid lowering compounds

Publications (1)

Publication Number Publication Date
ATE235487T1 true ATE235487T1 (de) 2003-04-15

Family

ID=8234538

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99964594T ATE235487T1 (de) 1998-12-22 1999-12-14 S-oxyde lipide senkende verbindungen

Country Status (12)

Country Link
US (1) US6451802B1 (de)
EP (1) EP1140917B1 (de)
JP (1) JP2002533339A (de)
AR (1) AR021969A1 (de)
AT (1) ATE235487T1 (de)
AU (1) AU761032B2 (de)
CA (1) CA2355822A1 (de)
DE (1) DE69906376T2 (de)
ES (1) ES2195653T3 (de)
MY (1) MY130851A (de)
NZ (1) NZ512891A (de)
WO (1) WO2000037463A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005230397B2 (en) * 2004-04-09 2010-04-08 Elanco Animal Health Ireland Limited Intermittent dosing regimen for the treatment of overweight with MTP-inhibitors
EP1890767A2 (de) * 2005-05-27 2008-02-27 Pfizer Products Inc. Kombinationstherapie zur behandlung von fettleibigkeit oder aufrechterhaltung des gewichtverlusts
ES2348530T3 (es) 2007-05-25 2010-12-09 Janssen Pharmaceutica, N.V. Síntesis mejorada de metanosulfonato de (2s-cis)-2-(bromometil)-2-(4-clorofenil)-1,3 dioxolan-4-metanol (éster).
US9790104B2 (en) * 2012-02-17 2017-10-17 Hydrafact Limited Water treatment
CN105980381A (zh) 2013-11-08 2016-09-28 拜耳医药股份有限公司 取代的尿嘧啶及其用途
CN111100112B (zh) * 2018-10-29 2021-05-04 浙江京新药业股份有限公司 苯并噻吩衍生物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000005I2 (de) 1994-10-27 2008-04-24 Janssen Pharmaceutica Nv Apolipoprotein-b syntheseinhibitoren

Also Published As

Publication number Publication date
AR021969A1 (es) 2002-09-04
AU761032B2 (en) 2003-05-29
EP1140917B1 (de) 2003-03-26
NZ512891A (en) 2003-01-31
DE69906376D1 (de) 2003-04-30
MY130851A (en) 2007-07-31
JP2002533339A (ja) 2002-10-08
DE69906376T2 (de) 2004-02-12
US6451802B1 (en) 2002-09-17
CA2355822A1 (en) 2000-06-29
EP1140917A1 (de) 2001-10-10
WO2000037463A1 (en) 2000-06-29
ES2195653T3 (es) 2003-12-01
AU3039500A (en) 2000-07-12

Similar Documents

Publication Publication Date Title
LTPA2009006I1 (lt) Trombopoetino junginiai
ATE229954T1 (de) Betacarbolinverbindungen
ID28266A (id) Senyawa-senyawa amidin
DE69733649D1 (de) Calcylitische verbindungen
DE69905038D1 (de) Cyclische boroprolinverbindungen
NO20011745L (no) Forbindelser
EE200100502A (et) Ühendid
FI4209U1 (fi) Uusia yhdisteitä
ATE222893T1 (de) Triazinylaminostilben verbindungen
DE69808403D1 (de) Tetradecachlorcyclohexasilandianon enthaltende Verbindungen
NO20005006D0 (no) Kalsilytiske forbindelser
ATE405580T1 (de) Antithrombotische verbindungen
DE69914594D1 (de) Aryl-annellierte azapolycyclische verbindungen
NO20006662L (no) Fluorfenylresin-forbindelser
ATE225364T1 (de) Bromotiacumicin verbindungen
ATE235487T1 (de) S-oxyde lipide senkende verbindungen
DE69908838D1 (de) Siloxy-Verbindungen
SE9800626D0 (sv) Compounds
SE9800458D0 (sv) Novel compounds
SE9804494D0 (sv) Novel compounds
SE9804493D0 (sv) Novel compounds
SE9804211D0 (sv) Novel compounds
SE9803669D0 (sv) Novel compounds
SE9801989D0 (sv) Novel compounds
SE9801397D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties